Tamoxifen - latest research news and features - Medical Xpress
Tamoxifen is an antagonist of the estrogen receptor in breast tissue and is therefore used in the treatment of breast cancer. As of 2004, it was the world's largest selling drug for that purpose.
Study Supports Tamoxifen for DCIS Early Breast Cancers - U.S. News …
Dec 16, 2024 · Women who took tamoxifen after undergoing a lumpectomy to remove ductal carcinoma in situ (DCIS) were 44% to 51% less likely to have their cancer return in that breast, researchers reported last...
Adjuvant Tamoxifen May Reduce Recurrence Risk for Patients …
Dec 12, 2024 · SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the same breast, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
Clinical trial: Adjuvant tamoxifen may reduce recurrence risk for ...
Dec 12, 2024 · For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in...
How breast cancer patients respond to tamoxifen may be linked …
Nov 25, 2024 · In the new study, the researchers set out to define the role that gut microbes play in how tamoxifen is processed (i.e., absorption, distribution, metabolism and excretion), given its significant...
Tamoxifen reduces ipsilateral recurrence risk for certain ... - Healio
Dec 12, 2024 · SAN ANTONIO — Tamoxifen lowered overall and invasive ipsilateral recurrence among women with “good-risk” ductal carcinoma in situ who opted for breast conservation surgery without radiation.
Tamoxifen Reduces Risk for Invasive Recurrence of DCIS
Dec 13, 2024 · SAN ANTONIO — For patients with so-called “good-risk” ductal carcinoma in situ (DCIS) who did not have radiation therapy after breast-conserving surgery, adjuvant tamoxifen reduced their overall...
Tamoxifen - latest research news and features - Phys.org
Tamoxifen is an antagonist of the estrogen receptor in breast tissue and is therefore used in the treatment of breast cancer. As of 2004, it was the world's largest selling drug for that purpose.
Scientists find why tamoxifen works better for some people
Nov 25, 2024 · Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.
Scientists Find Why Tamoxifen Works Better for Some People
Nov 25, 2024 · A new study shows that variation in a patient’s gut microbiome can impact how effective Tamoxifen is at preventing breast cancer recurrence.